Background: The use of feeding tubes (FTs) in patients with advanced dementia does not yield positive health outcomes and can have a negative effect. Methods: A cross-sectional study assessed the knowledge and attitudes of physicians on the use of FTs for patients with advanced dementia. Results: 201 of 240 doctors (83.8%) participated in the study; 61.7% of the doctors claimed that FTs prevent aspiration, 51.7% that they prevent pneumonia, and 38.8% that they prevent weight gain. Almost one-third (32.3%) said that the decision to use FTs could be taken by a hospitalist or a primary physician (28.9%). Conclusion: We found large gaps in knowledge among doctors about the use of FTs and consequences in patients with advanced dementia. medical teams often use enteral feeding by means of a feeding tube (FT) in the form of nasogastric tubes (NGT) or a percutaneous endoscopic gastrostomy (PEG). The rate of use of FTs is in the range of 4.7-20.5% in the USA and Canada [11, 12] and 26-53% in Israel [13, 14] .
Introduction
Eating problems are a common manifestation of dementia. The prevalence of eating disorders in advanced dementia ranges from 13 to 86% [1] [2] [3] and increases as the disease progresses [4] [5] [6] . Eating problems in advanced dementia are associated with an increased risk of pneumonia [7, 8] , high fever and hospitalization [1] , apathy and hallucinations [9] , and high mortality rates [1, 3, 5, 7, 10] . To manage eating problems in patients with advanced dementia,
Results
In all, 201 doctors (83.8%) completed the study questionnaire; 89/110 doctors were hospital-based (80.9%) and 112/130 were community-based (86.1%). The mean age was 41.1 ± 10.7 years and 105 (52.2%) were male. The mean seniority was 11.3 ± 11.2 years. Forty-nine doctors (24.4%) were board-certified in family medicine, and 38 (18.9%) in internal medicine. The sociodemographic characteristics of the participating doctors are presented in Table 1 .
In answer to the questions related to indications for the use of FTs (Table 2) , 124 doctors (61.7%) claimed that FTs were meant to prevent aspiration, 51.7% that they prevent aspiration pneumonia, 38.8% that they prevent weight loss, 26 .9% that they prolong life, 26 .4% that they improve quality of life, and 21.4% that they prevent pressure sores. Only 36 doctors (17.9%) showed "sufficient knowledge" by answering "No" to the question on indications for the use of FTs in patients with advanced dementia. Community-based doctors were more Values express n (%), unless stated otherwise. likely than hospital-based doctors to think that the use of FTs prevents pneumonia (28.6 vs. 12.4%, p = 0.006) and weight loss (58.9 vs. 42.7%, p = 0.024). Residents were more likely than board-certified doctors to answer that indications for the use of FTs include the prevention of aspiration (70.3 vs. 51.1%, p = 0.006) and pneumonia (27.0 vs. 14.4%, p = 0.038).
In terms of decision-making, 149 doctors (74.1%) thought that the decision to use FTs should be made by the patients themselves within the framework of advanced medical directives, and 133 (66.2%) thought it should be made by a legal guardian. However, close to one-third of the doctors (32.3%) thought that the decision could also be made by an emergency-room or hospital-ward doctor, primary physician (28.9%), or family member (24.4%). Furthermore, 13.3% believed that the decision should be taken by a judge or social worker (5%). Compared to hospital-based doctors, more community-based doctors thought that a judge should decide on the use of an FT (18.8 vs. 6.7%, p = 0.013). Board-certified doctors were more likely than residents to say that the decision should be made by the patients themselves within the framework of advanced medical directives (80.2 vs. 66.7%, p = 0.036).
The doctors cited the following potential complications with the use of FTs: perforation (67.7%), gastrointestinal tract bleeding (63.7%), the appearance of new pressure sores in the area of the FT (52.7%), and agitation (46.3%). Some doctors thought that there are no complications associated with the use of FTs (12.4%). Board-certified doctors were more knowledgeable than residents as to the potential complications of FTs including diarrhea (36.3 vs. 21.6%, p = 0.027) or new pressure sores (61.1 vs. 45.0%. p = 0.034). There were no significant differences in the level of knowledge about potential complications between the hospitalbased and community-based doctors.
The doctors were asked about their preferences relating to insertion of a FT if they themselves suffered from advanced dementia ( Table 3) . One hundred and thirty-nine doctors (69.2%) answered that they would not agree to FT insertion if they suffered from advanced dementia with eating problems. Only 8.5% stated that they would prefer to be treated with an FT. Only 7% would like that their close family members reach the decision, and 15.4% would agree that the medical team decide. In comparison to the other doctors, fewer of the 36 with sufficient knowledge would prefer to have an FT inserted in a similar situation (2.8 vs. 9.7%) or that the medical team reach the decision for them (11.1 vs. 16.4%).
When asked about the factors that affect the decision on the use of FTs, 50.7% said that the medical education that they had received would affect their decision as to whether to have an FT if they suffered from advanced dementia. Smaller percentages of doctors cited legal considerations (35.8%), religion and faith (35.3%), or family considerations (29.4%) as factors that could influence their personal decision. They were no significant differences on these issues between hospital-based or community-based doctors or between board-certified doctors and residents.
Discussion
In this study, we evaluated doctors' knowledge and attitudes towards enteral feeding of patients with advanced dementia and eating problems. We found significant gaps in knowledge among the doctors about the indications for FTs, with only 36 doctors (17.9%) answering that there is in fact no indication for the use of FTs in these patients (based on recommendations in the medical literature [31, 34] ).
The widespread use of FTs in patients with advanced dementia has been reported previously in the literature, and possible reasons for FT use include the lack of a preparatory discussion with family members [13, 38] , religious and/or cultural considerations [39, 40] , legal considerations [41] , the attitudes of the medical team [35] , a lack of medical team knowledge [36] , or unrealistic expectations on the part of doctors [14, 37, 38, 42] . Compared to the study by Teno et al. [36] , we did not find significant gaps in knowledge or differences in attitudes between hospital-based and community-based doctors, with one exception, i.e., that significantly more community-based doctors thought that the use of FTs would prevent weight loss and pneumonia. The comparison between board-certified doctors and residents also did not show significant differences in knowledge and attitudes in favor of the more senior doctors, with the exception of a few isolated parameters.
A high percentage of participating doctors thought that doctors, social workers, and judges should be responsible for the decision about the use of FTs. This finding is of concern, as it could explain the widespread use of FTs and is consistent with previous reports that the use of FTs is primarily based on the decisions made by doctors without involving the patient or their family [13, 35, 38, 43] . We found that board-certified doctors, compared to residents, were less likely to think that the decision should be reached by the patients within the framework of advanced medical directives (66.7 vs. 80.2%, p = 0.036). It is not clear if this finding can be explained by the assumption that younger doctors are less paternalistic and more likely to give autonomy to their patients, or that more senior doctors are more influenced by their ongoing clinical experience.
In the past, a gap was reported between the exaggerated expectations of doctors about the use of FT and their own personal preferences [37] . In a study by Carmel [44] that evaluated differences in attitudes between doctors and patients on the use of FTs in irreversible severe physical conditions and irreversible mental illness, for both conditions the doctors were more likely to recommend the use of FTs for patients than for themselves. Our findings present a similar picture. Irrespective of the level of knowledge (senior doctors vs. residents) or the work setting (i.e., hospital-based vs. community-based doctors), over two-thirds of the doctors in our study were inclined to avert the use of FTs should they themselves suffer from advanced dementia, compared to only 8.5% who would be prepared to have an FT themselves in these circumstances. Do doctors have a different approach to treating themselves compared to their patients? Or are they incapable of resisting environmental pressure (i.e., work procedures, the health system, or the patient's family) and "reserve the right" to reach the "correct" decision only for themselves? This issue is worthy of further study.
Another interesting finding that has not been reported previously is that only a minority of doctors would agree that the medical team (15.4%) or their family members (7.0%) decide for them on the use of an FT, should they suffer from advanced dementia. This finding highlights the need to establish realistic expectations about the use of FTs in advance, on the part of patients and their relatives on the one hand and the medical team on the other. It also emphasizes the importance of implementing advance medical directives when patients are still at the stage of relatively mild dementia [45] .
Most of the doctors noted that the most important factor that affects their decision on the use of an FT, should they themselves suffer from advanced dementia, is the medical education that they received (50.7%). Previous studies have shown that intervention programs designed to improve the level of doctors' knowledge about the use of FTs in patients with advanced dementia succeeded in changing the attitudes of these doctors and reduced the use of FTs significantly [46, 47] . The finding that most of the doctors had only partial knowledge about the use of FTs strengthens the need to raise their level of knowledge on this subject during residency training and throughout the years of continuing medical education.
This study has several advantages. It included a relatively large sample of doctors with a response rate > 80%, in contrast to previous studies in which the response rate ranged between 28 and 53% [37, 48, 49] . We also had a low number of incomplete responses and equal representation of hospital-based and community-based doctors, and of board-certified doctors and residents. To our knowledge, this is the first study in Israel that has evaluated the knowledge and attitudes of a large and varied group of doctors on the subject of FTs.
The study also has limitations. First, regarding the sample population, the investigators did not have access to the medical-team meetings in all of the small clinics and not all doctors attended the meetings at which the questionnaire was administered. This limits our ability to generalize the results from this population to all doctors. Another significant limitation stems from the nature of the study. We assessed the knowledge and attitudes of doctors, but not their actual practice in the clinical setting. Thus, we cannot determine if the results of the study reflect a lack of experience on the part of doctors in the treatment of patients with advanced dementia, or a lack of sufficient training in this area. Finally, the small number of doctors with "sufficient knowledge" did not enable us to conduct further analyses on the factors that influence the use of FTs.
Conclusions
The results of this study demonstrate large gaps in knowledge among doctors on enteral feeding for patients with advanced dementia. They highlight the need for the development of a training program for doctors on the treatment of patients with advanced dementia in general, and enteral feeding in particular. To improve the current situation, guidance should also be provided for patients, especially those in the early stages of cognitive decline. Efforts should also be invested to promote the awareness of advanced medical directives.
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